THIS TRAINING ON PHARMACEUTICAL STABILITY STUDIES 2015 - Stability Program to Support Shipping and Distribution of Drug Products
View: 215
Website http://bit.ly/1ASq1Wv |
Edit Freely
Category FDA GXP Compliance - Pharmaceuticals
Deadline: February 11, 2015 | Date: February 11, 2015
Venue/Country: Palo Alto, U.S.A
Updated: 2015-02-10 19:44:58 (GMT+9)
Call For Papers - CFP
This training on pharmaceutical stability studies will highlight the key factors that would affect the shipping and distribution of drug products. It will explain the stability studies that need to be done to support shipping and distribution of drugs.Why Should You Attend:A drug product must maintain its identity, strength, quality and purity till its expiration. Physical, chemical and biological data are influenced by various environmental factors such as temperature, humidity and light. In current manufacturing environment, products can be shipped and distributed across different climatic zones. Seasonal changes as well as types of transportation can greatly affect the supply chain of the products.Who Will Benefit:Pharmaceutical scientistsManufacturers of raw material and ingredientsAnalysts and lab managersQA managers and personnelInstructor Profile:Kim Huynh-Ba has almost 25 years of experience in analytical development, project management, strategic drug development and stability sciences. She is the executive director of Pharmalytik, where she provides consulting and training services to pharmaceutical companies including companies operating under FDA’s consent decree on harmonization and optimization of analytical best practices.
Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.